SFM
CERE

Soros Fund Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,151,641
Closed -$88M 229
2024
Q2
$88M Buy
2,151,641
+211,440
+11% +$8.65M 1.58% 10
2024
Q1
$82M Buy
+1,940,201
New +$82M 1.36% 13